Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors.FDA decision on market authorization of ProSense® for ...

IceCure Medical has regained compliance with Nasdaq’s minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. This milestone indicates the company’s stabilized ...

Icecure Medical ( ) has issued an update. IceCure Medical has received an Intention to Grant Notice from the European Patent Office for its innovative cryogenic system connector t ...

Lung cancer liver metastases are tumors that form in the liver ... Techniques include radiofrequency ablation, microwave ablation, and cryoablation. Compared to surgery, both of these procedures ...

IceCure Medical’s next-generation cryoablation technology to receive European patent: Caesarea, Israel Monday, January 6, 2025, 13:00 Hrs [IST] IceCure Medical Ltd., a developer ...

About IceCure Medical IceCure Medical (Nasdaq: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy ... bone and lung cancer. Its minimally invasive technology is a ...

This meta-analytical study compared the efficacy of cryoablation and radiofrequency ablation (RFA) in treating non-small cell lung cancer (NSCLC). We searched PubMed, Cochrane, Embase, and Web of ...

New research from the University of St Andrews School of Medicine has found that biomarker testing in individuals at risk of ...

The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA ...

Scientists have found that a test to detect circulating tumor DNA can predict lung cancer outcome. Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to ...

A new test, developed by researchers from UCL Cancer Institute and the Francis Crick Institute, can better predict lung cancer survival at the point of diagnosis, which could inform treatment ...